NCT03746431 2026-01-07A Phase 1 Study of [225Ac]-FPI-1434 InjectionFusion Pharmaceuticals Inc.Phase 1 Terminated78 enrolled
NCT02637531 2022-04-04A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549Infinity Pharmaceuticals, Inc.Phase 1 Unknown219 enrolled